Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial

BACKGROUND: von Hippel-Lindau disease (VHL) is a multisystem cancer syndrome caused by mutations in the VHL gene. Retinal hemangioblastoma is one of the most common tumours, and when it appears near the optic nerve, its treatment is challenging and risky. To date, no treatment has proven effective i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Open Ophthalmol
Main Authors: González-Rodríguez, Beatriz, Villar Gómez de las Heras, Karina, Aguirre, Daniel T, Rodríguez-Padial, Luis, Albiñana, Virginia, Recio-Poveda, Lucía, Cuesta, Angel M, Botella, Luisa Mª, Jiménez-Escribano, Rosa María
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6557078/
https://ncbi.nlm.nih.gov/pubmed/31245608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2018-000203
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares